ESTRO37_ProgrammeBook

> Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC D. De Ruysscher (The Netherlands), A. Dingemans, J. Praag, J. Belderbos, C. Tissing-Tan, G. Herder, T. Haitjema, F. Ubbels, F. Lagerwaard, J. Stigt, E. Smit, H. Van Tinteren, V. Van der Noort, H. Groen > Cardiovascular disease and survival in lung cancer: a multicenter prospective assessment D. Herrero Rivera (Spain), J.M. Nieto-Guerrero Gómez, J. Cacicedo Fernández de Bobadilla, D.B. Delgado, A. Sanchez-Camacho Mejías, J.J. Gordito Soler, J.M. Praena Fernández, M.V. Enguix, M.J. Ortiz Gordillo, J.L. López Guerra > Lung cancer 3D-CRT: Evaluation of V5 constraint compliance and incidence of radiation pneumonitis M. Colomer (Spain), M. Núñez, G. Frontera, T. Ramírez, R. Gómez, E. Ambroa, J. García-Miguel, A. López, D. Amat, M. Parcerisa, R. Pujol, D. Navarro > High local control for lung SBRT of comorbid patients: prospective monocenter phase II STRIPE trial S. Adebahr (Germany), U. Nestle, K. Kaier, T. Schimek-Jasch, E. Gkika, F. Momm, G. Becker, A.L. Grosu > Generation of tumor-regression CT during definitive CCRT of the lung cancer using deep learning K.S. Kim (Republic of Korea), M.Y. Kim, H.Y. Kim, C.W. Choi, K.M. Yang > Stereotactic body radiotherapy for stage I lung cancer P.M. Samper Ots (Spain), C. Vallejo Ocaña, P. Alcantara, M.D.M. Puertas, M. Rico Osés, M.L. Couselo, A. Sotoca Ruiz, J. Luna Tirado, J.L. Monroy, P. Almendros Blanco > DART-bid with VMAT for locally advanced NSCLC R. Pinter (Austria), K. Wurstbauer, M. Kazil, M. Meinschad, P. Cerkl, T. Künzler, P. Clemens, A. De Vries > Role and Timing of Radiotherapy for Limited-Disease Small Cell Lung Cancer M. Koh (Republic of Korea), S.Y. Song, S.S. Kim, J.H. Kim, S.D. Ahn, S.W. Lee, S.M. Yoon, Y.S. Kim, J.H. Park, J.H. Jung, E.K. Choi

ELECTRONIC POSTERS

EP-1366

EP-1367

EP-1368

EP-1369

EP-1370

EP-1371

EP-1372

EP-1373

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

274